Article

Rx for Uncomplicated Psoriasis

This article reviews topical and systemic treatments for uncomplicated psoriasis.

Drugs for Psoriasis. The Medical Letter on Drugs and Therapeutics. 57(1470):81. June 8, 2015

 

This is a review of topical and systemic treatments for uncomplicated psoriasis.

Mild to moderate psoriasis is generally treated with topical corticosteroids. Vitamin D analogs and tazarotene can be added. The adverse effect profiles of methotrexate and cyclosporine are compared. Phototherapy and systemic therapy, including biologics, are recommended for moderate to severe disease.

Once again, biologics are the most expensive and appear to be most effective, and offer Psoriasis Area Severity Index (PASI) 75 responses for 70% to 80% of patients after 12 weeks.

(The more ambitious goals of PASI 90 and complete clearance, floated recently in the Lancet, are not discussed here.)

Related Videos
Laure Gossec, MD, PhD: Informing Physician Treatment Choices for Psoriatic Arthritis
Exploring CAR T-cell Therapy for Rheumatic/Autoimmune Diseases With Georg Schett, MD
Uncovering the Role of COVID-19 in Rheumatic Disease, with Leonard Calabrese, DO
Comparing Treatment Options for Psoriatic Arthritis with Philip Mease, MD
Melodie Young, ASN, RN: Updates on Therapies for Pediatric Patients with Psoriasis, PsA
Harnessing Patient Insights: The Role of PROs in Managing Psoriasis and Psoriatic Arthritis
Upcoming Research in PsA, AxSpa, with Philip Mease, MD
Philip Mease, MD, Clinical Professor, University of Washington School of Medicine and Director, Rheumatology Research, Swedish Medical Center
MEDcast logo
© 2024 MJH Life Sciences

All rights reserved.